Skip to content
PubMed This is a summary of 27 peer-reviewed journal articles Updated
Neurology · Focal Sensory Seizures

How Is the Best Medicine Chosen for Focal Sensory Seizures?

At a Glance

There is no single best medication for focal sensory seizures. Neurologists choose among lamotrigine, levetiracetam, oxcarbazepine, and lacosamide by balancing seizure control with side effects, other health conditions, drug interactions, pregnancy plans, cost, and the patient's daily routine.

There is no single “best” medication for focal sensory seizures (also called focal-onset seizures with sensory symptoms, or partial sensory epilepsy). Instead, the best choice is the one that minimizes your specific seizures while causing the fewest side effects, based on your unique health profile [1].

When your neurologist chooses between common anti-seizure medications (ASMs) like lamotrigine, levetiracetam, oxcarbazepine, and lacosamide, they are matching the drug’s evidence and side-effect profile to your age, medical history, reproductive plans, and lifestyle. Treatment is highly individualized; a medication that works perfectly for one person may not be appropriate for another [1].

Comparing the Main Options

While lamotrigine, levetiracetam, oxcarbazepine, and lacosamide are all effective for focal seizures, they have distinct profiles:

  • Lamotrigine: This medication has strong clinical evidence as a first-line option and favorable pregnancy data [2][3]. However, it carries a rare but serious risk of a severe skin rash, requiring a very slow start [4].
  • Levetiracetam: Known for being easy to dose, this drug has very few interactions with other medications [5]. Its most notable risk is a higher rate of mood changes, such as irritability, anxiety, or depression [6][7].
  • Oxcarbazepine: A strong option for focal seizures, but it carries a specific risk of hyponatremia (abnormally low blood sodium levels), which can cause dizziness and fatigue [8].
  • Lacosamide: A newer alternative that has few drug interactions, but it can affect the electrical conduction system of the heart, requiring caution in those with underlying heart issues [9][10].

Matching the Medication to Your Health Profile

To personalize your treatment, your doctor will evaluate several key aspects of your health:

Psychiatric History

If you have a history of depression, severe anxiety, or irritability, your doctor may discuss lamotrigine as a preferred starting point over levetiracetam. Research shows that levetiracetam is more likely to cause or worsen psychiatric symptoms compared to lamotrigine, though this varies widely from person to person [7][6]. Having a psychiatric history does not automatically rule out levetiracetam, but it requires careful monitoring.

Heart Health

Lacosamide can prolong the PR interval—a measure of how fast electrical signals travel through the heart [10]. If you are older, have a history of heart disease, bradycardia (slow heart rate), or take conduction-slowing medications like beta-blockers, lacosamide is used with extra caution [11][12]. In these cases, a baseline and follow-up electrocardiogram (ECG) is often recommended based on your specific risk [13]. You should seek immediate medical attention if you experience fainting, severe lightheadedness, or unusually slow heartbeats while taking lacosamide.

Liver and Kidney Function

Your organs process medications differently. Levetiracetam is primarily cleared from the body by your kidneys, meaning its dose must be carefully adjusted if you have kidney impairment [14]. Conversely, if you have severe liver disease, levetiracetam is sometimes preferred because it places very little processing burden on the liver compared to other anti-seizure drugs [3].

Hyponatremia and Bone Health

Oxcarbazepine carries a notable risk of hyponatremia (abnormally low blood sodium) [8]. Older adults, women, and those taking diuretic medications (water pills) are at a higher risk [15]. If you take oxcarbazepine, your doctor will likely monitor your blood sodium shortly after starting the drug and after any dose changes [16]. Additionally, oxcarbazepine acts as a mild enzyme inducer, meaning it speeds up how your body breaks down other substances, including vitamin D. For older adults, doctors carefully weigh the use of enzyme-inducing medications against the long-term risk of bone loss and osteoporosis [1][17].

Family Planning and Reproductive Health

If you are a person capable of becoming pregnant, reproductive health will heavily influence your medication choice.

  • Pregnancy Safety: Neurologists often consider lamotrigine and levetiracetam favorable options for women planning a pregnancy, as large registries show they have lower risks of major congenital malformations compared to some older ASMs [3][18]. Evidence for lacosamide in pregnancy is much more limited [19].
  • Preconception Planning: Anyone with epilepsy who might become pregnant should take daily folic acid starting before conception to help protect fetal development [20]. The recommended dose varies, so ask your clinician what is right for you.
  • Contraceptive Interactions: Oxcarbazepine can speed up the metabolism of hormonal contraceptives, reducing their effectiveness and increasing the risk of unintended pregnancy [21]. Conversely, estrogen-containing birth control pills can accelerate the breakdown of lamotrigine, significantly reducing its effectiveness against seizures [21].
  • Pregnancy Monitoring: Pregnancy changes how your body clears medications. Blood levels of lamotrigine and levetiracetam often drop during pregnancy, meaning your doctor may need to increase your dose to prevent breakthrough seizures [22]. Crucially, medication clearance returns to normal rapidly after delivery; a dose that was increased during pregnancy must be promptly reassessed postpartum to prevent serious toxicity [22].

Logistics, Cost, and Shared Decision-Making

Drug interactions and daily routines are major factors in shared decision-making [23]. If you take multiple medications, your doctor may prefer levetiracetam or lacosamide, as they have fewer drug-drug interactions [5][24]. Convenience also matters, because missing doses increases the risk of seizures [25]. If you have trouble taking pills multiple times a day, your doctor might look for extended-release options. Costs and insurance coverage also vary widely, making your financial priorities a valid part of the medical conversation [26].

The Process: Start Low and Go Slow

Once a medication is chosen, you will undergo gradual titration, starting at a very low dose and slowly increasing it over weeks. This allows your body to adjust and minimizes early side effects like dizziness, fatigue, or cognitive fogginess [4].

For lamotrigine, a very slow titration schedule is critical to reduce the risk of a rare but life-threatening allergic skin reaction [4].

Red Flag Warning: If you are taking an ASM, particularly lamotrigine or oxcarbazepine, and develop a new rash accompanied by fever, facial swelling, blisters, or mouth/eye sores, seek emergency care immediately [27].

Essential Safety Rules

  • Never stop abruptly: Stopping an ASM suddenly can cause withdrawal seizures or prolonged, life-threatening seizures [18]. Contact your prescriber before stopping.
  • Missed doses: Ask your pharmacist exactly what to do if you miss a dose for your specific medication. Never double up on a dose to “catch up” unless explicitly instructed.
  • Seizure Emergencies: Seek emergency medical care (call 911) if a seizure lasts 5 minutes or longer, if repeated seizures occur without recovery in between, or if there is difficulty breathing after a seizure.

What Happens Next?

Finding the best medication often involves trial and adjustment. You will start your new medication, keep a seizure and side-effect diary, and attend follow-up visits to review your lab work or ECGs. If your seizures continue or side effects are unacceptable, your neurologist will discuss switching to a different medication, trying a combination therapy, or referring you to an epilepsy specialist for further evaluation.

Common questions in this guide

What is the best medication for focal sensory seizures?
There is no single best medication for everyone. Neurologists weigh seizure control, side effects, other health conditions, drug interactions, pregnancy plans, cost, and how easily you can follow the dosing schedule. Common options include lamotrigine, levetiracetam, oxcarbazepine, and lacosamide.
How do lamotrigine and levetiracetam compare for focal seizures?
Lamotrigine has strong evidence for focal seizures and generally favorable pregnancy data, but it must be increased slowly because of a rare serious skin reaction. Levetiracetam is easy to dose and has few drug interactions, but it is more likely to cause mood changes such as irritability, anxiety, or depression. Individual responses vary.
What health conditions affect the choice of focal seizure medicine?
Kidney impairment can change the dose of levetiracetam, while severe liver disease may make it an attractive option because it places little processing burden on the liver. Oxcarbazepine can cause low blood sodium, especially in older adults, women, or people taking diuretics. Lacosamide needs extra caution with heart disease, a slow heart rate, or medicines that slow heart conduction.
Can focal seizure medicines affect pregnancy or birth control?
Lamotrigine and levetiracetam are often considered favorable options during pregnancy, but every treatment plan needs individual review. Oxcarbazepine can reduce the effectiveness of hormonal birth control, while estrogen-containing birth control can lower lamotrigine levels. People who may become pregnant should discuss folic acid before conception and medication-level monitoring during pregnancy and after delivery.
How are anti-seizure medicines started safely?
Most are started at a low dose and increased gradually to reduce early side effects. Never stop an anti-seizure medicine suddenly or double a missed dose unless your prescriber tells you to. A new rash with fever, facial swelling, blisters, or mouth or eye sores requires emergency medical care, particularly with lamotrigine or oxcarbazepine.
When is a seizure an emergency?
Call emergency services if a seizure lasts 5 minutes or longer, if seizures repeat without recovery between them, or if the person has trouble breathing afterward. Fainting, severe lightheadedness, or an unusually slow heartbeat while taking lacosamide also requires immediate medical attention.

Questions For You

Answer a question to get research tailored to you. Your answers are private.

Get notified when new evidence is published on partial sensory epilepsy.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.How do lamotrigine, levetiracetam, oxcarbazepine, and lacosamide compare for my specific seizure type, comorbid conditions, and personal priorities?
  2. 2.If we select lacosamide, will I need a baseline ECG based on my age and my other heart medications?
  3. 3.If I take oxcarbazepine, what is the exact schedule for testing my blood sodium levels to ensure they remain safe?
  4. 4.How will my hormonal birth control interact with my antiseizure medication, and what backup contraceptive methods should I discuss with my gynecologist?
  5. 5.What is my specific step-by-step titration schedule, and what early side effects or warning signs warrant a same-day call to the clinic?

References

References (27)
  1. 1

    Antiseizure Medications for Adults With Epilepsy: A Review.

    Kanner AM, Bicchi MM

    JAMA 2022; (327(13)):1269-1281 doi:10.1001/jama.2022.3880.

    PMID: 35380580
  2. 2

    Antiepileptic drug monotherapy for epilepsy: a network meta-analysis of individual participant data.

    Nevitt SJ, Sudell M, Cividini S, et al.

    The Cochrane database of systematic reviews 2022; (4()):CD011412 doi:10.1002/14651858.CD011412.pub4.

    PMID: 35363878
  3. 3

    Epilepsy treatment in adults and adolescents: Expert opinion, 2016.

    Shih JJ, Whitlock JB, Chimato N, et al.

    Epilepsy & behavior : E&B 2017; (69()):186-222 doi:10.1016/j.yebeh.2016.11.018.

    PMID: 28237319
  4. 4

    Cenobamate tablets as a treatment for focal-onset seizures in adults.

    Steinhoff BJ

    Expert review of clinical pharmacology 2021; (14(2)):161-172 doi:10.1080/17512433.2021.1879637.

    PMID: 33470139
  5. 5

    Management of epilepsy in brain tumor patients.

    van der Meer PB, Taphoorn MJB, Koekkoek JAF

    Current opinion in oncology 2022; (34(6)):685-690 doi:10.1097/CCO.0000000000000876.

    PMID: 35838207
  6. 6

    The Adverse Effects of Commonly Prescribed Antiseizure Medications in Adults With Newly Diagnosed Focal Epilepsy.

    Barnard SN, Chen Z, Kanner AM, et al.

    Neurology 2024; (103(7)):e209821 doi:10.1212/WNL.0000000000209821.

    PMID: 39270150
  7. 7

    Psychiatric Outcomes of Antiseizure Medications in Newly Diagnosed Focal Onset Epilepsy: From the Human Epilepsy Project Cohort Study.

    Altalib HH, Nuthalapati P, Zhang Z, et al.

    Neurology. Clinical practice 2026; (16(5)):e200645 doi:10.1212/CPJ.0000000000200645.

    PMID: 42574692
  8. 8

    Carbamazepine- and oxcarbazepine-induced hyponatremia in people with epilepsy.

    Berghuis B, van der Palen J, de Haan GJ, et al.

    Epilepsia 2017; (58(7)):1227-1233 doi:10.1111/epi.13777.

    PMID: 28542738
  9. 9

    Efficacy, safety, and tolerability of lacosamide monotherapy versus controlled-release carbamazepine in patients with newly diagnosed epilepsy: a phase 3, randomised, double-blind, non-inferiority trial.

    Baulac M, Rosenow F, Toledo M, et al.

    The Lancet. Neurology 2017; (16(1)):43-54 doi:10.1016/S1474-4422(16)30292-7.

    PMID: 27889312
  10. 10

    Lacosamide cardiac safety: clinical trials in patients with partial-onset seizures.

    Rudd GD, Haverkamp W, Mason JW, et al.

    Acta neurologica Scandinavica 2015; (132(5)):355-63 doi:10.1111/ane.12414.

    PMID: 25933358
  11. 11

    Serious adverse effects of selected antiseizure medications used for treatment of focal onset seizures.

    Milosavljević M, Janković SM

    Expert opinion on drug safety 2025; (24(2)):129-143 doi:10.1080/14740338.2024.2446416.

    PMID: 39714228
  12. 12

    Recurrent bradycardia and hypotension after Oral Lacosamide during hospital boarding in the emergency department: A case report.

    Gorham JW, Pope JV, Wischmeyer JS, Babineau MR

    The American journal of emergency medicine 2026; (108()):23-25 doi:10.1016/j.ajem.2026.05.040.

    PMID: 42258903
  13. 13

    Cardiac effects of rapid intravenous loading of lacosamide in patients with epilepsy.

    Kim HK, Lee H, Bae EK, Kim DW

    Epilepsy research 2021; (176()):106710 doi:10.1016/j.eplepsyres.2021.106710.

    PMID: 34265537
  14. 14

    Antiseizure medication dosing and monitoring in the intensive care unit: a practical narrative review.

    Webb AJ, Barlow B, Seto SL, et al.

    Intensive care medicine 2026; (52(10)):2144-2159 doi:10.1007/s00134-026-08550-y.

    PMID: 42455344
  15. 15

    Predicting oxcarbazepine-induced hyponatremia in adult epilepsy patients: A multicenter machine learning analysis using real-world CDM data.

    Jung G, Lee J, Gho SM, et al.

    Seizure 2025; (133()):167-174 doi:10.1016/j.seizure.2025.10.004.

    PMID: 41166858
  16. 16

    Symptomatology of carbamazepine- and oxcarbazepine-induced hyponatremia in people with epilepsy.

    Berghuis B, Hulst J, Sonsma A, et al.

    Epilepsia 2021; (62(3)):778-784 doi:10.1111/epi.16828.

    PMID: 33576502
  17. 17

    Antiseizure Medications in Older Adults with Epilepsy: Considerations in Pharmacology, Safety, Tolerability, and Effectiveness of Newer Agents.

    McCarthy LM, Boylan KA, Sarkis RA

    Drugs & aging 2026; (43(3)):251-265 doi:10.1007/s40266-026-01283-z.

    PMID: 41706289
  18. 18

    Risk factors for adverse maternal‑neonatal outcomes in pregnant women with epilepsy and the impact of different anti-seizure medications exposures on neonatal birth weight.

    Fang C, Yang H, Yang Y

    Epilepsy research 2026; (227()):107899 doi:10.1016/j.eplepsyres.2026.107899.

    PMID: 42659781
  19. 19

    Levetiracetam for epilepsy: an evidence map of efficacy, safety and economic profiles.

    Yi ZM, - , Wen C, et al.

    Neuropsychiatric disease and treatment 2019; (15()):1-19 doi:10.2147/NDT.S181886.

    PMID: 30587993
  20. 20

    Teratogenesis, Perinatal, and Neurodevelopmental Outcomes After In Utero Exposure to Antiseizure Medication: Practice Guideline From the AAN, AES, and SMFM.

    Pack AM, Oskoui M, Williams Roberson S, et al.

    Neurology 2024; (102(11)):e209279 doi:10.1212/WNL.0000000000209279.

    PMID: 38748979
  21. 21

    Issues of Women with Epilepsy and Suitable Antiseizure Drugs.

    Lee SK

    Journal of epilepsy research 2023; (13(2)):23-35 doi:10.14581/jer.23005.

    PMID: 38223363
  22. 22

    Antiseizure Medication Concentrations During Pregnancy: Results From the Maternal Outcomes and Neurodevelopmental Effects of Antiepileptic Drugs (MONEAD) Study.

    Pennell PB, Karanam A, Meador KJ, et al.

    JAMA neurology 2022; (79(4)):370-379 doi:10.1001/jamaneurol.2021.5487.

    PMID: 35157004
  23. 23

    Current challenges in focal epilepsy treatment: An Italian Delphi consensus.

    Di Gennaro G, Lattanzi S, Mecarelli O, et al.

    Epilepsy & behavior : E&B 2024; (155()):109796 doi:10.1016/j.yebeh.2024.109796.

    PMID: 38643659
  24. 24

    Which treatment strategy in patients with epilepsy with focal seizures uncontrolled by the first anti-seizure medication?

    Zaccara G, Lattanzi S, Brigo F

    Epilepsy & behavior : E&B 2021; (121(Pt A)):108031 doi:10.1016/j.yebeh.2021.108031.

    PMID: 33992932
  25. 25

    Seizure control, delivery, and neonatal outcomes in pregnant women with focal epilepsies: a prospective cohort study.

    Melikova S, Mammadbayli A

    Seizure 2025; (134()):117-125 doi:10.1016/j.seizure.2025.11.018.

    PMID: 41352322
  26. 26

    Which is the most cost-effective antiseizure medication for initial monotherapy for focal epilepsy?

    Hu Y, Chen S, Mao F, et al.

    Epilepsia 2025; (66(4)):1129-1142 doi:10.1111/epi.18269.

    PMID: 39841033
  27. 27

    Post-marketing safety of antiseizure medications: Focus on serious adverse effects including drug reaction with eosinophilia and systemic symptoms (DRESS).

    Qian J, Xue X, Ezeja L, et al.

    Seizure 2025; (125()):37-43 doi:10.1016/j.seizure.2025.01.002.

    PMID: 39787827

This page explains how clinicians individualize anti-seizure medication choices for focal sensory seizures. It is for informational purposes only and does not constitute medical advice; discuss medication, pregnancy, and safety decisions with your neurologist.